Study: Bed rest linked to improved growth in small for gestational age fetuses
A study found that 2 weeks of maternal bed rest significantly increases fetal weight and growth metrics in small for gestational age fetuses.
14-year-old girl presents with chest pain, 2-week history of vomiting
The patient had increased her vape use recently, but did not disclose when she started, or how much she vaped.
Study reveals pain management challenges in premature babies
Swedish study highlights challenges in managing pain for preterm infants, revealing disparities in pain treatment and assessment across neonatal care.
Sudden unexpected infant death is increasing, new study finds
From 1999 to 2022, a 24.2% decrease in infant mortality was observed in the US, however, SUID mortality rates increased by nearly 12% from 2020 to 2022.
FDA accepts sNDA for higher regimen nusinersen for spinal muscular atrophy
The higher dose regimen of nusinersen comprises a more rapid loading regimen, two 50 mg doses 14 days apart, and higher maintenance regimen, 28 mg, every 4 months.
Tina Tan, MD discusses the increased outbreaks of norovirus this year
Based on recent reports, norovirus outbreaks in the 2024-2025 seasonal year is above the range reported from the 2012-2020 and 2021-2024 seasonal years.
IXCHIQ chikungunya vaccine meets phase 2 endpoint in children
Already approved in those aged 18 and older in the United States, Valneva has submitted label extension applications to the FDA for IXCHIQ use in adolescents aged 12 to 17 years.
Detectable THC biomarkers among children via in-home, second-hand cannabis smoke
Detectable TTE in children's urine were 'significantly higher' in homes with reported in-home cannabis smoking.
AAP: These tips can keep kids comfortable amid cold & flu season
During the current cold and flu season, children have a higher risk of getting sick. The AAP has release tips and reminders for parents to help keep children comfortable and healthy.
ARS launches program to provide free neffy in eligible K-12 schools
Eligible schools have the opportunity to receive 2 cartons of epinephrine nasal spray for use in emergency situations to treat type I allergic reactions, including anaphylaxis.
Study: No association between montelukast and neuropsychiatric adverse event risk
"In aggregation with other robust observational studies, these results can inform the management of asthma and allergic rhinitis in this patient group," wrote the study authors.
Pediatric obesity treatment yields lower morbidity, mortality risk in young adults
"The greatest risk reductions were demonstrated in those who experienced obesity remission during childhood," stated study authors.
Discussing pediatric vaccination with vaccine-hesitant parents
Robert Frenck, MD, offers several practical tips to use when discussing pediatric vaccination among vaccine-hesitant parents.
Pediatric pulmonary arterial hypertension and the pediatrician
Principal investigator Lewis Romer, MD, of Johns Hopkins Medicine joined us to discuss the actively-recruiting MoD PAH trial, and explains the role the pediatrician can play in care and recruitment.
Weekly review: New neffy PDUFA, crinecerfont discussion for CAH, and more
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
Calling out signs of addictive behavior around social media or binge eating
Susan Carnell, PhD, highlights the nuanced relationship between social media use and binge eating in adolescents, noting the importance of addressing addictive behaviors and seeking support when needed.
HHS expands Medicare drug price negotiations to add 15 medications
HHS selects 15 more Medicare Part D drugs for price negotiation under the Inflation Reduction Act, aiming to lower costs for millions by 2027.
Quick reactions to the FDA ban of FD&C red No. 3
Read these quick comments from Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, and Bernard Cohen, MD, regarding the banning of red No. 3 from foods and ingested drugs.
FDA expands immobilized lipase cartridge clearance down to 1 year
The digestive enzyme cartridge is designed to mimic pancreatic lipase function.
CDC: Most US teens fail to get recommended 8 hours of sleep, report finds
A CDC report shows only 23% of U.S. teens get enough sleep, with disparities highlighting the need for targeted health interventions.
CDC: 2013-2023 youth risk physical activity behavior report
Across all years in the report, the CDC rated each physical activity trend with a color of red, indicating that trends are going in the "wrong direction."
Kyriakie Sarafoglou, MD, discusses crinecerfont FDA approval for congenital adrenal hyperplasia
The lead clinical trial investigator for a phase 3 study of crinecerfont in pediatric CAH patients breaks down the December 2024 FDA approval.
Despite decreases of invalid vaccine doses, series completion still lacks
Of those with a minimum age or minimum interval vaccine dose, 44.9% ended up receiving extra doses to complete a vaccination series.
Investigating mono vs dual therapy for pediatric pulmonary arterial hypertension
Principal investigator Lewis Romer, MD, of Johns Hopkins Medicine joined us to discuss the actively-recruiting MoD PAH trial assessing mono vs dual therapy for pediatric PAH.
PDUFA date set for neffy 1 mg for children who weigh 33 lbs or more
Neffy was first approved in September 2024 to treat type 1 allergic reactions in patients who weigh at least 66 lbs (33 kg).
Weekly review: New peanut patch data, norovirus outbreaks, and more
Addictive behaviors surrounding social media could lead to binge eating
Results from a recent study revealed that compulsive and addictive elements can contribute to the risk of disordered eating. Study investigator Susan Carnell, PhD, explains these findings.
Data: 80% of INZ-701-treated infants with ENPP1 Deficiency survived past first year
Positive interim data was reported from the ENERGY 1 trial and Expanded Access Program that featured a total of 5 infants and 1 child.
New data: Viaskin Peanut patch improves treatment benefit through 36 months
In an open-label extension of the EPITOPE phase 3 trial, the Viaskin Peanut patch had continued improvement in toddlers aged 1-3 years through 36 months.
CDC: 2024-2025 seasonal norovirus outbreaks up from previous years
Based on reports by NoroSTAT-participating states, the total number of outbreaks in 2024-2025 seasonal year is above the range reported 012–2020 and 2021-2024 seasonal years.
